Recent Posts
- FDA Okays Blood Test for Ovarian Cancer
- Replication At DNA Damage Sites Highlights Fanconi Anemia And Breast Cancer Proteins
- ASCO To Hold Annual Meeting In Chicago For The Next Ten Years: City Seen As Best Choice To Host Meeting That Continues To Grow
- Protein Partnership Leads To Pediatric Tumor Regression
- ASCO Awarded CEO Cancer Gold Standard: Achievement Underscores Organization’s Commitment To The Health And Well-Being Of Its Employees
Random Posts
- How The Body Prevents Formation Of Blood Vessels Has Implications For Cancer Treatment
- Bio-Matrix Scientific Group And Therinject LLC Begin Development Of Tumor Banking Facility In Conjunction With Cancer Therapeutic Vaccine
- Gene Mutation Linked To Type Of Childhood Cancer
- Paul Marks Prize Recognizes Three Young Cancer Researchers
- Older Cancer Patients With Depression Can Be Treated Effectively With Collaborative Approach In Primary-Care Settings
- CRT To Licence Telomere Targeting Agents To Pharminox For Drug Development
- ASCO: Results 'Striking' for New Kidney Cancer Drug (CME/CE)
- GlaxoSmithKline Withdraws Its Marketing Authorisation Application For Zunrisa (casopitant Mesilate)
- No Reduction in Transfusions with ESAs (CME/CE)
- Cost of Cancer Drugs to Force Hard Decisions
Prescription Cancer Drugs
American Society Of Clinical Oncology (ASCO) Statement On Cuts To Cancer Care In 2010 Medicare Physician Fee Schedule
Posted by: admin in Prescription Cancer Drugs on November 03rd, 2009
Below is a statement for attribution to ASCO CEO Allen S. Lichter, MD:
“Today, CMS issued its physician fee schedule for 2010. The schedule included a one percent cut to oncology services in 2010, part of an overall six percent reduction in reimbursement for cancer care over the next four years. We are deeply concerned that these cuts will continue to erode access to cancer care in the United States.
“The cumulative effect of previous cuts has already caused oncologists to close practices, consolidate locations, and turn away Medicare patients. Further reductions will jeopardize access to care for more people with cancer across the country. Oncology cannot sustain additional cuts at a time when the number of people with cancer is increasing, practice expenses continue to rise, and the oncology workforce is dwindling.”
ASCO’s fee schedule fact sheet summarizes how cuts in Medicare coverage to date have already affected patient care, forcing physicians to close practices, consolidate locations, and turn away Medicare patients.
Source
American Society of Clinical Oncology
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URL
Leave a comment
You must be logged in to post a comment.